Brain infarction associated with antiphospholipid antibody syndrome caused by paradoxical embolism through patent foramen ovale [4]

Journal of Neurology

Volumn 251, Issue 6, 2004, Pages 757-759

  Ago, Tetsuro ^a   Ooboshi, Hiroaki ^a   Kitazono, Takanari ^a   Imamura, Tsuyoshi ^a   Takada, Junichi ^a   Ibayashi, Setsuro ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; BLOOD PRESSURE MONITORING; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DOPPLER FLOWMETER; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARADOXICAL EMBOLISM; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR ENDOTHELIUM;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BRAIN INFARCTION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; FEMORAL VEIN; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE;

EID: 3042572727     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. Carreras LO, Vermylen JG (1982) "Lupus" anticoagulant and thrombosis - possible role of inhibition of prostacyclin formation. Thromb Haemost 48:38-40
2. Feldmann E, Levine SR (1995) Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options. Ann Neurol 37(Suppl 1):S114-S130
3. Fulham MJ, Gatenby P, Tuck RR (1994) Focal cerebral ischemia and antiphospholipid antibodies: a case for cardiac embolism. Acta Neurol Scand 90:417-423
4. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544-1547
5. Greaves M (1999) Antiphospholipid antibodies and thrombosis. LANCET 353:1348-1353
6. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993-997
7. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318:1148-1152
8. Lockshin MD (1992) Antiphospholipid antibody syndrome. JAMA 268:1451-1453
9. Malia RG, Kitchen S, Greaves M, Preston FE (1990) Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 76:101-107
10. Martinuzzo ME, Maclouf J, Carreras LO, Levy-Toledano S (1993) Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost 70:667-671
11. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740-1746
12. Meister SG, Grossman W, Dexter L, Dalen JE (1972) Paradoxical embolism. Diagnosis during life. Am J Med 53:292-298
13. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, Brainin M, Homma S, Sacco RL (1998) Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29:944-948
14. Verro P, Levine SR, Tietjen GE (1998) Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 29:2245-2253
15. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL (1988) Patent foramen ovale in young stroke patients. Lancet 2:11-12